Onyebuchi J. Ononogbu is a dynamic and driven individual with a strong dedication to advancing pharmacy practice and improving patient outcomes. Currently serving as a Research Assistant Professor in the Department of Pharmacy Practice and Translational Research and a Hematology/Oncology Clinical Pharmacy Specialist at Harris Health System Research, Ononogbu's expertise lies in cancer health disparities, quality improvement, and diversity/equity inclusion within healthcare.

Her educational journey has been marked by excellence, culminating in the attainment of a Doctor of Pharmacy degree from the University of the Incarnate Word Feik School of Pharmacy in San Antonio, TX, where she graduated Cum Laude. Prior to this, she completed her Bachelor of Science in Allied Health and Diagnostic Sciences at the University of Connecticut, Storrs, CT.

Ononogbu's commitment to advancing pharmacy practice is evident through her research contributions, including publications in prestigious journals such as Clinical Lymphoma, Myeloma and Leukemia, and presentations at various conferences. Her work focuses on critical issues such as adherence to oral endocrine therapy, clinical outcomes in acute lymphoblastic leukemia, and optimizing chemotherapy administration processes.

In addition to her academic and research pursuits, Ononogbu is actively involved in professional organizations such as the Hematology Oncology Pharmacy Association and the American Society of Health-System Pharmacists. She also co-founded the Pharmacy Initiative Leaders (PILs), demonstrating her leadership skills and commitment to fostering innovation in pharmacy practice.

Ononogbu's contributions have been recognized through numerous awards and honors, including the Patient Advocate Award from the American College of Clinical Pharmacy Hematology/Oncology Practice and Research Network. Her passion for improving patient care and advancing the pharmacy profession underscores her role as a leader and innovator in the field.